Emmanuel Papadakis
Stock Analyst at Deutsche Bank
(3.99)
# 1,771
Out of 4,988 analysts
1020
Total ratings
52.4%
Success rate
4.1%
Average return
Main Sectors:
Stocks Rated by Emmanuel Papadakis
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SWX: NOVN Novartis AG | Reiterated: Hold | CHF 120.00 | CHF 115.10 | +4.26% | 140 | Sep 15, 2026 | |
| LON: AZN AstraZeneca PLC | Upgraded: Hold | 11,500p → 11,700p | 12,500p | -6.40% | 196 | Sep 15, 2026 | |
| LON: GSK GSK plc | Reiterated: Hold | 2,000p | 1,878p | +6.52% | 174 | Sep 15, 2026 | |
| EPA: SAN Sanofi | Reiterated: Buy | €95.00 | €74.05 | +28.29% | 147 | Sep 14, 2026 | |
| BNTX BioNTech SE | Reiterated: Buy | $140 | $96.06 | +45.74% | 33 | Aug 26, 2026 | |
| SWX: ROP Roche Holding AG | Reiterated: Hold | CHF 340.00 | CHF 356.80 | -4.71% | 141 | Jul 24, 2026 | |
| STO: SOBI Swedish Orphan Biovitrum AB (publ) | Reiterated: Buy | kr 285.00 → kr 515.00 | kr 447.00 | +15.21% | 18 | Jul 21, 2026 | |
| SWX: SDZ Sandoz Group AG | Reiterated: Hold | CHF 70.00 → CHF 65.00 | CHF 68.62 | -5.28% | 9 | Apr 30, 2026 | |
| NVO Novo Nordisk | Downgraded: Hold | n/a | $43.24 | - | 16 | Feb 23, 2026 | |
| ARGX argenx SE | Downgraded: Hold | n/a | $990.32 | n/a | 2 | Sep 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | €11.00 → €12.00 | €9.54 | n/a | 28 | Aug 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | €12.00 → €14.00 | €10.44 | n/a | 12 | Jul 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | €22.00 | €24.98 | n/a | 13 | Apr 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Hold | n/a | $42.48 | n/a | 4 | Jan 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | CHF 1.00 | CHF 4.84 | n/a | 11 | Nov 29, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Hold | $85 → $80 | $154.04 | n/a | 13 | Aug 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $1,152.93 | n/a | 1 | Jul 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $8 → $14 | $5.87 | n/a | 6 | Jul 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Hold | n/a | $7.31 | n/a | 2 | Jun 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | €95.00 → €124.00 | €155.90 | n/a | 3 | Aug 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | n/a | $54.15 | n/a | 3 | Jan 18, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $34.74 | n/a | 1 | Nov 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | €44.00 | €52.70 | n/a | 1 | Aug 9, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $127 → $58 | $28.55 | n/a | 2 | Aug 6, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | n/a | $50.22 | n/a | 5 | Apr 16, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $21.54 | n/a | 2 | Jul 15, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | €80.00 | €48.09 | n/a | 31 | Jul 14, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | €62.00 → €78.00 | €129.85 | n/a | 2 | Jan 15, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | n/a | $140.37 | n/a | 4 | Dec 7, 2018 |
Novartis AG
Sep 15, 2026
Reiterated: Hold
Price Target: CHF 120.00
Current: CHF 115.10
Upside: +4.26%
AstraZeneca PLC
Sep 15, 2026
Upgraded: Hold
Price Target: 11,500p → 11,700p
Current: 12,500p
Upside: -6.40%
GSK plc
Sep 15, 2026
Reiterated: Hold
Price Target: 2,000p
Current: 1,878p
Upside: +6.52%
Sanofi
Sep 14, 2026
Reiterated: Buy
Price Target: €95.00
Current: €74.05
Upside: +28.29%
BioNTech SE
Aug 26, 2026
Reiterated: Buy
Price Target: $140
Current: $96.06
Upside: +45.74%
Roche Holding AG
Jul 24, 2026
Reiterated: Hold
Price Target: CHF 340.00
Current: CHF 356.80
Upside: -4.71%
Swedish Orphan Biovitrum AB (publ)
Jul 21, 2026
Reiterated: Buy
Price Target: kr 285.00 → kr 515.00
Current: kr 447.00
Upside: +15.21%
Sandoz Group AG
Apr 30, 2026
Reiterated: Hold
Price Target: CHF 70.00 → CHF 65.00
Current: CHF 68.62
Upside: -5.28%
Novo Nordisk
Feb 23, 2026
Downgraded: Hold
Price Target: n/a
Current: $43.24
Upside: -
argenx SE
Sep 11, 2025
Downgraded: Hold
Price Target: n/a
Current: $990.32
Upside: n/a
Aug 5, 2025
Reiterated: Hold
Price Target: €11.00 → €12.00
Current: €9.54
Upside: n/a
Jul 28, 2025
Reiterated: Buy
Price Target: €12.00 → €14.00
Current: €10.44
Upside: n/a
Apr 28, 2025
Reiterated: Hold
Price Target: €22.00
Current: €24.98
Upside: n/a
Jan 30, 2025
Upgraded: Hold
Price Target: n/a
Current: $42.48
Upside: n/a
Nov 29, 2024
Reiterated: Hold
Price Target: CHF 1.00
Current: CHF 4.84
Upside: n/a
Aug 6, 2024
Upgraded: Hold
Price Target: $85 → $80
Current: $154.04
Upside: n/a
Jul 17, 2024
Reiterated: Hold
Price Target: n/a
Current: $1,152.93
Upside: n/a
Jul 2, 2024
Reiterated: Hold
Price Target: $8 → $14
Current: $5.87
Upside: n/a
Jun 18, 2024
Upgraded: Hold
Price Target: n/a
Current: $7.31
Upside: n/a
Aug 7, 2023
Reiterated: Hold
Price Target: €95.00 → €124.00
Current: €155.90
Upside: n/a
Jan 18, 2023
Downgraded: Sell
Price Target: n/a
Current: $54.15
Upside: n/a
Nov 11, 2022
Downgraded: Hold
Price Target: n/a
Current: $34.74
Upside: n/a
Aug 9, 2022
Reiterated: Hold
Price Target: €44.00
Current: €52.70
Upside: n/a
Aug 6, 2021
Downgraded: Hold
Price Target: $127 → $58
Current: $28.55
Upside: n/a
Apr 16, 2021
Reiterated: Sell
Price Target: n/a
Current: $50.22
Upside: n/a
Jul 15, 2020
Reiterated: Hold
Price Target: n/a
Current: $21.54
Upside: n/a
Jul 14, 2020
Reiterated: Buy
Price Target: €80.00
Current: €48.09
Upside: n/a
Jan 15, 2019
Reiterated: Sell
Price Target: €62.00 → €78.00
Current: €129.85
Upside: n/a
Dec 7, 2018
Downgraded: Sell
Price Target: n/a
Current: $140.37
Upside: n/a